Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000690734 | SCV000818434 | pathogenic | Aortic valve disease 2 | 2018-02-20 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln290*) in the TBX5 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with TBX5-related disease. Loss-of-function variants in TBX5 are known to be pathogenic (PMID: 16183809, 16917909). For these reasons, this variant has been classified as Pathogenic. |
Centre de Biologie Pathologie Génétique, |
RCV000782303 | SCV000920822 | pathogenic | Holt-Oram syndrome | 2018-06-14 | no assertion criteria provided | clinical testing |